Trump Administration to Require Most Green Card Seekers to Leave U.S. First
New policy mandates that most immigrants in the U.S. must return to their home countries to apply for permanent residency, limiting the adjustment of…
Archive 
Experts Question Legal Basis of Trump’s $1.8 Billion Anti-Weaponization Fund
The Justice Department’s newly created fund to compensate alleged victims of government "weaponization" faces scrutiny over its legality, transparency, and potential for misuse
Trump Withdraws Voluntary AI Regulatory Order Citing Innovation Concerns
President Trump canceled an executive order aiming to establish voluntary AI cybersecurity frameworks, favoring speed over regulation amid calls from tech leaders
Democracies Struggle to Provide Universal Safe Drinking Water in Developing Nations
Study finds democracies lag behind non-democracies in ensuring safe water despite slightly better basic water access
Hubble Captures Lenticular Galaxy NGC 1266 in Transition
NASA’s Hubble Space Telescope reveals NGC 1266, a lenticular galaxy showing features between spiral and elliptical types, about 100 million light-years away
Parental Wealth Strongly Influences Homeownership Chances, Study Finds
New research shows adult homeownership relies more on parents’ wealth than personal income, especially in high-cost housing markets
GOP Senators Challenge DOJ on $1.8 Billion “Anti-Weaponization Fund”
Republican senators criticized the Justice Department’s new fund designed to compensate alleged abuse of the legal system, questioning its purpose and oversight during a…
House Republicans Delay Vote on Iran War Resolution Amid Uncertainty
House Republicans postponed a vote on a measure restricting President Trump’s war powers in Iran, despite indications it had enough support to pass
Rubio Rejects Iran’s Strait of Hormuz Toll Proposal Amid Peace Talks
U.S. Senator Marco Rubio criticized Iran’s plan to impose tolls on the Strait of Hormuz, urging alternative strategies as indirect negotiations show limited progress
FDA Approves First Drug for Chronic Hepatitis Delta Infection
Hepcludex (bulevirtide) is the first FDA-approved treatment for chronic hepatitis delta virus infection, offering a new option for patients at risk of severe liver…